Advertisement

Topics

Axovant Sciences Announces Presentation Time Change at Oppenheimer Healthcare Conference

12:57 EDT 20 Mar 2017 | PR Newswire
This article has expired, however you can still download the PDF.
Preview:
BASEL, Switzerland, March 20, 2017 /PRNewswire/ -- Axovant Sciences (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced a change to the company's presentation time at the Oppenhei...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Axovant Sciences Announces Presentation Time Change at Oppenheimer Healthcare Conference"

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Dementia
Dementia describes a range of symptoms of cognitive decline. For example memory loss, problems with reasoning and communication skills, and a reduction in a person's abilities and skills in carrying out daily activities. There are about 820,000 peo...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...